Then, in 2015, three independent studies using genotyping and imputation-based fine-mapping, pointed to rs3731249 in exon 2 of CDKN2A as the hit associated variant that conferred high risk for B-ALL in European and Hispanic children [15–17]. Here, CDKN2A is linked to acute lymphoblastic leukemia.